These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Management of Chronic Active Antibody-Mediated Rejection in Renal Transplant Recipients: Single-Center Experience. Nair P; Gheith O; Al-Otaibi T; Mostafa M; Rida S; Sobhy I; Halim MA; Mahmoud T; Abdul-Hameed M; Maher A; Emam M Exp Clin Transplant; 2019 Jan; 17(Suppl 1):113-119. PubMed ID: 30777534 [TBL] [Abstract][Full Text] [Related]
10. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients. Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R Clin Transpl; 2014; ():215-21. PubMed ID: 26281148 [TBL] [Abstract][Full Text] [Related]
11. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience. Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614 [TBL] [Abstract][Full Text] [Related]
12. Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy. Mainra R; Xu Q; Chibbar R; Hassan A; Shoker A Transpl Immunol; 2013 Jun; 28(4):145-7. PubMed ID: 23685054 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. Jordan SC; Tyan D; Stablein D; McIntosh M; Rose S; Vo A; Toyoda M; Davis C; Shapiro R; Adey D; Milliner D; Graff R; Steiner R; Ciancio G; Sahney S; Light J J Am Soc Nephrol; 2004 Dec; 15(12):3256-62. PubMed ID: 15579530 [TBL] [Abstract][Full Text] [Related]
14. Use of high-dose human immune globulin in highly sensitized patients on the kidney transplant waiting list: one center's experience. Gozdowska J; Urbanowicz A; Perkowska-Ptasinska A; Michalska K; Chmura A; Szmidt J; Durlik M Transplant Proc; 2009 Oct; 41(8):2997-3001. PubMed ID: 19857660 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of renal biopsies showing concurrent acute rejection and tacrolimus-associated tubular vacuolization. Randhawa PS; Saad RS; Jordan M; Scantlebury V; Vivas C; Shapiro R Transplantation; 1999 Jan; 67(1):85-9. PubMed ID: 9921801 [TBL] [Abstract][Full Text] [Related]
16. Effect of histological damage on long-term kidney transplant outcome. Nankivell BJ; Fenton-Lee CA; Kuypers DR; Cheung E; Allen RD; O'Connell PJ; Chapman JR Transplantation; 2001 Feb; 71(4):515-23. PubMed ID: 11258430 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Indication Biopsies ≥5 Years After Kidney Transplant: A Single-Center Experience. Tatar E; Simsek C; Tasli F; Cayhan VK; Karatas M; Uslu A Exp Clin Transplant; 2017 Feb; 15(Suppl 1):265-268. PubMed ID: 28260483 [TBL] [Abstract][Full Text] [Related]
18. Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients. Pilon C; Bigot J; Grondin C; Thiolat A; Lang P; Cohen JL; Grimbert P; Matignon M Front Immunol; 2020; 11():34. PubMed ID: 32038663 [TBL] [Abstract][Full Text] [Related]
19. Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab. Kahwaji J; Jordan SC; Najjar R; Wongsaroj P; Choi J; Peng A; Villicana R; Vo A Transpl Int; 2016 Dec; 29(12):1276-1285. PubMed ID: 27529314 [TBL] [Abstract][Full Text] [Related]
20. Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients. Billing H; Rieger S; Ovens J; Süsal C; Melk A; Waldherr R; Opelz G; Tönshoff B Transplantation; 2008 Nov; 86(9):1214-21. PubMed ID: 19005402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]